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Inclusion criteria 
Studies:  
Randomized or quasi-randomized controlled trials 
comparing cholera vaccines with placebo, control 
vaccines, or no intervention. 
Participants: 
Well adults or children.  
Intervention: 
Killed cholera vaccines administered by any route. 
Outcomes: 
Cholera cases; death; systemic and local side effects. 
 
 
Results 
• 25 trials included (18 efficacy trials and 11 safety 
trials). The 18 efficacy trials included over 2.6 
million participants and the 11 safety trials 
included 9342 adults and children. Allocation 
concealment was adequate in 23 trials.  
• All types of vaccines prevent cholera at 1 year 
(relative risk 0.51, 95% confidence interval 0.42 to 
0.61); and the vaccines remain effective in year 2 
(relative risk 0.51, 95% confidence interval 0.42 to 
0.62). 
• The risk of contracting cholera in year 3 increases; 
and by years 4 and 5 the vaccines are no longer 
effective.  
• Children under 5 years were only protected for up 
to 1 year following vaccination, while protection 
for older children and adults extended up to 3 
years. 
• Injected vaccines were associated with increased 
systemic and local side effects compared with 
placebo, while oral vaccines were not.  
  
Do cholera vaccines prevent cholera? 
Single dose cholera vaccines tested to date provide partial protection 
for people living in endemic areas for up to 2 years. 
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Authors’ conclusions 
Implications for practice:  
Cholera vaccines can provide protection for populations living in endemic areas for up to 2 years following a 
single dose, and for 3 to 4 years with annual booster. There are little data on the effect of cholera vaccines in 
visitors to endemic areas. 
Implications for research: 
Further trials are needed to evaluate immunization for preventing cholera epidemics, to estimate the most 
effective dose of oral vaccine for children, and to compare new live oral vaccines with killed vaccines.  
The Cochrane Database of Systematic Reviews is available from www.wiley.com, and free for eligible countries through www.healthinternetwork.org.  
